By
Neimeth International Pharmaceuticals Plc is considering raising fresh capital from the Nigerian capital market to support its working capital and expansion plans.
Speaking at a media parley in Lagos, Managing Director/CEO Valentine Okelu revealed that the company’s management will hold a strategy session within a month to decide on the move.
He explained that Neimeth’s expansion focuses on two key areas: modernizing its existing Oregun plant and developing a new state-of-the-art manufacturing facility.
The decision, once finalized, will strengthen the company’s position in the pharmaceutical industry and boost its production capacity.
